REQUEST A DEMO
Total
USD $0.00
Search more companies

Sn Genelab Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sn Genelab Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sn Genelab Private Limited is an unlisted company, incorporated on 16/12/2013. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2013PTC077903 and registration number is 077903.

Legal Address
2Nd Floor, A Tower, President Plaza, Near Rto Circle, Nanpura, Ring Road,
Surat; Gujarat; Postal Code: 395001

Contact Details: Purchase the Sn Genelab Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sn Genelab Private Limited report to view the information.
Outstanding Shares:
Purchase the Sn Genelab Private Limited report to view the information.
Registered Capital:
Purchase the Sn Genelab Private Limited report to view the information.
Incorporation Date:
December 16, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
45%
Purchase this report to view the information.
45%
Company Performance
Financial values in the chart are available after Sn Genelab Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
7.28%
Total operating revenue
7.55%
Operating profit (EBIT)
-34.17%
EBITDA
-28.72%
Net Profit (Loss) for the Period
-34.31%
Total assets
13.18%
Total equity
22.87%
Operating Profit Margin (ROS)
-7.67%
Net Profit Margin
-5.75%
Return on Equity (ROE)
-16.2%
Debt to Equity Ratio
-12.11%
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?